Comodo Health, Inc is a privately owned specialty pharmaceuticals company based in Basking Ridge, New Jersey. Comodo Health is engaged in development, regulatory approval and commercialization of niche hospital injectables, as well as drug/device combination products for respiratory diseases. Comodo Health has successfully partnered with a leading European pharmaceutical company for its development and manufacturing capabilities. Together, we are moving our projects forward to regulatory approval, and subsequently commercialization of Comodo Health products.
In The Pipeline
We currently have 5 injectables in our pipeline pending submission to FDA, with others currently in development stage. Our goal is to file at least three or more Abbreviated New Drug Applications (ANDAs) every year to develop a robust portfolio of injectable products.
In addition to injectables, we have invested in large scale drug/device combination product manufacturing for respiratory diseases. We already have one such product currently in clinical stage of development with favorable view by the FDA so far with two others in preclinical stages.
We are always eager in acquiring, licensing and/or partnering in other products for the US market outside our internal capabilities, provide necessary funding and expertise to further the project and deliver strong commercial results to help increase value of the product; thus, increasing value of Comodo Health and our partners.
Almost 8 out of 10 Prescriptions filled in the United States are for generic drugs.
These drugs are used to treat complex, chronic and often costly diseases.
Up to 24 Million Americans have evidence of impaired lung function.
Patients preferences for dry powder inhalers well documented.